Guidance for industry : minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies.

Format:

• Book
• Government document

Contributor:

• Center for Biologics Evaluation and Research (U.S.)

Language:

English

Subjects (All):

• Fetal blood.
• Hematopoiesis.
• Hematoma.
• Blood banks--Licenses--United States.
• Fetal Blood.
• Blood banks--Licenses.
• United States.

Medical Subjects:

• Fetal Blood.
• Hematopoiesis.
• Hematoma.

Physical Description:

1 online resource (ii, 46 pages)

Other Title:

Minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies

Place of Publication:

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

Notes:

• Title from PDF title page (viewed on May 11, 2009).
• "Draft guidance."
• "December 2006."
• Includes bibliographical references (page 46).

OCLC:

320778975